Thrombosis, Embolism and Infarction Flashcards
what is thrombosis
pathologic formation of intravascular blood clot
where can thrombi occur
in veins or arteries
most commonly thrombi are found in and originate from
deep veins of lower extremities (leg)
characteristics of thrombi
- Lines of Zahn (alternating layers of platelets, fibrin and red blood cells)
- attached to vessel walls
what is Virchow’s Triad of formation
- Endothelial damage
- Alterations in normal blood flow
- Hypercoagulability
Normally, thrombosis is prevented bc
- Intact endothelium limits exposure to subendothelial collagen and tissue factor
- Endothelial cells produce prostacyclin and nitric oxide- inhibit vasodilation and platelet aggregation
- Endothelial cells produce substances which inhibit thrombin and coagulation factors
- Secrete tissue plasminogen activator
- Secrete thrombomodulin
endothelial damage can be defined as
any disturbance in dynamic balance of endothelium can lead to thrombosis
physical loss of endothelium leads to
- exposure of subendithelial ECM
- aggregation of platelets
- release of TF
- local depletion of prostaglandins and plasminogen activators
how does endothelial cell dysfunction disturb balance
convert procoagulant factors to anticoagulant effectors
name 3 causes of endothelial cell damage
- atherosclerosis
- increased homocysteine levels
- vasculitis
normal blood flow is
laminar - platelets flow centrally in vessel lumen, separated from endothelium by slower moving plasma
what can cause alteration in blood flow
- turbulence
2. stasis
what is turbulence
countercurrents and pockets of stasis contribute to arterial and cardiac thrombi
what is stasis
contributes to venous thrombi (slow moving blood)
ulcerated atherosclerotic plaques cause
turbulence and exposure to ECM
aneurysms cause
local stasis
myocardial infarctions cause
stasis and flow abnormalities
mitral valve stenosis cause
left atrial dilation
arterial fibrillation and stasis
hyperviscosity causes
- polycythemia
2. sickle cell anemia
what is polycythemia
small vessel stasis and increased resistance to blood flow
what is sickle cell anemia
vascular occlusion
other clinical settings for thrombosis
- arterial aneurysms in myocardial infarction
- immobilization (causes DVT)
- trauma, surgery, burns associated with reduced physical activity
- cardiac failure
- malignancies associated with tumour-associated tissue thromboplastic release (called migratory trombophlebitis)
hypercoagulability/thrombophilia due to increased
procoagulation or defective anticoagulation
inherited forms of hypercoagulability/thrombophilia
- patients present with deep venous thrombosis at young age
- usually veins of leg are involved
name 4 inherited hypergoaulable diseases
- Factor V Mutation/Leiden mutation
- Prothrombin 20210A
- Protein C/S deficiency
- Antithrombin III deficiency
Factor V Leiden has a mutated form of factor
V therefore lack cleave site for deactivation by protein C and S
Factor V Mutation presents in –% of Caucasians
2-15%
Factor V mutation is one of the most common reasons for inherited
hypercoagulation
do homozygous and heterozygous pts have an increase risk of thrombosis with a factor V mutation
homozygous
what happens in pts with heterozygous genes for factor V mutation
propensity for thrombosis with other acquired risk factors:
- pregnancy
- prolonged best rest
- long airplane flights
prothrombin 20210A is what type of mutation
point mutation in prothrombin - increased gene expression
prothrombin 20210A increases
thrombin increases chance of thrombosis
Protein C/S deficiency decreases
negative feedback on coagulation cascade
describe Warfarin skin necrosis
Protein C/S deficiency causes skin thrombosis at onset of warfrin therapy (normally, warfarin causes temporary deficiency of protein C and S in normal individuals)
the drug warfarin is given to patients with
thrombosis
what is heparin
an anticoagulant
mechanism of action of heparin
- given to patients to prevent thrombosis
- acts by binding and activating antithrombin III
what happens to patients with antithrombin III deficiency
heparin is unable to find to antithrombin III and anticoagulation is not achieved
pts with antithrombin III deficiency is given —- insntead
Coumadin
Name 2 acquired hypercoaulable states
- Heparin induced thrombocytopenia
2. antiphospholipid antibody syndrome/ lupus anticoagulant syndrome
when does heparin induced thrombocytopenia occur
following administration of unfractionated heparin
what happens in heparin induced thrombocytopenia
induces antibodies which recognize complexes of heparin and platelet factor 4 on the surface of platelets
heparin induced thrombocytopenia can lead to
thrombocytopenia
prothrombotic state
what is used instead of unfractionated heparin
newer low molecular weight fractionated heparins - less incidence of HIT
see slide 25
see slide 25
clinical presentation of Antiphopholipid Antibody Syndrome/ Lupus Anticoagulant syndrome
- recurrent thrombosis
- repeated miscarriages
- cardiac valve vegetations
- thromboytopenia
- pulmonary embolism
- bowel infarction
- renovascular hypertension